Nanoparticle technology for drug delivery: from nanoparticles to cutting-edge delivery strategies - part II.
Shekunov
Boris
B
Ferro Corporation Pharmaceutical Technologies, Independence, OH 44131, USA. shekunovb@ferro.com
D000818:Animals; D003460:Crystallization / Q000379:methods; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D019344:Lactic Acid / Q000008:administration & dosage / Q000737:chemistry; D008081:Liposomes / Q000008:administration & dosage / Q000737:chemistry; D051379:Mice; D049329:Nanostructures / Q000737:chemistry*; D036103:Nanotechnology / Q000191:economics / Q000379:methods* / Q000639:trends; D043942:Nanotubes / Q000737:chemistry; D011100:Polyglycolic Acid / Q000008:administration & dosage / Q000737:chemistry; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers / Q000008:administration & dosage / Q000737:chemistry; D051381:Rats; D013678:Technology, Pharmaceutical / Q000379:methods / Q000639:trends
D008081:Liposomes; D011108:Polymers; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid